Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 52, Status: Authorised
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 7, Status: Authorised
New recommendations to strengthen supply chains of critical medicines
Executive Steering Group on Shortages and Safety of Medicinal Products
MSSG recommendations to strengthen supply chains of critical medicinal products
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products
Member states contact points for review of national versions of the content of mobile scanning and other technologies
Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages
Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group